| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 54.78B | 52.68B | 48.59B | 46.53B | 37.99B | 35.25B |
| Gross Profit | 17.45B | 16.16B | 12.02B | 15.00B | 12.21B | 11.53B |
| EBITDA | 13.34B | 12.62B | 9.02B | 11.93B | 10.20B | 9.62B |
| Net Income | 8.47B | 7.87B | 5.68B | 7.90B | 6.74B | 6.14B |
Balance Sheet | ||||||
| Total Assets | 63.18B | 65.90B | 56.62B | 52.45B | 45.53B | 39.00B |
| Cash, Cash Equivalents and Short-Term Investments | 13.89B | 16.32B | 6.12B | 9.84B | 9.86B | 10.23B |
| Total Debt | 80.00M | 349.00M | 512.00M | 578.70M | 874.43M | 737.32M |
| Total Liabilities | 9.35B | 11.31B | 8.70B | 8.91B | 8.33B | 7.24B |
| Stockholders Equity | 53.39B | 54.13B | 47.60B | 43.54B | 37.20B | 31.76B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 12.07B | 372.00M | 1.93B | 1.12B | 5.83B |
| Operating Cash Flow | 0.00 | 14.20B | 4.23B | 4.74B | 4.45B | 5.94B |
| Investing Cash Flow | 0.00 | -2.74B | -5.10B | -3.41B | -3.44B | -771.47M |
| Financing Cash Flow | 0.00 | -2.15B | -2.13B | -2.08B | -1.64B | -1.51B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥184.82B | 14.19 | ― | 1.40% | 13.28% | 46.33% | |
75 Outperform | ¥301.70B | 0.79 | 164.12% | ― | -12.14% | ― | |
72 Outperform | ¥1.29T | 12.95 | 14.94% | 2.00% | 16.43% | 53.76% | |
72 Outperform | ¥681.82B | 12.93 | ― | 2.15% | -5.20% | -1.20% | |
65 Neutral | ¥655.26B | 6.30 | -0.24% | 2.10% | -0.41% | 80.25% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
55 Neutral | ¥137.18B | -3.11 | -33.76% | 0.96% | -5.80% | -126.63% |